The Ethics of Screening and Treating Persons with Hepatitis C: A Canadian Perspective

  • Ramseyer Apau Bediako Centre for Bioethics, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, Canada
Keywords: public funding, hepatitis C, screening program, vulnerable populations, resource allocation, eradication

Abstract

In this article, I argue that the Canadian government’s position against screening for hepatitis C virus (HCV) and publicly funding HCV treatment is ethically unjustifiable. Cost of medication and likelihood of widening existing health inequality are the government’s argument for not funding HCV treatment and for also not having a screening program. I object to this position and argue in favour of a screening program and public funding of HCV treatment. I argue that these barriers are ethically unjust. Conclusively, being denied screening and early treatment is to be denied the best possible outcome.

Published
2020-07-20
How to Cite
1.
Apau Bediako R. The Ethics of Screening and Treating Persons with Hepatitis C: A Canadian Perspective. Can. J. Bioeth. [Internet]. 2020Jul.20 [cited 2020Oct.24];3(1):52-7. Available from: https://cjb-rcb.ca/index.php/cjb-rcb/article/view/155
Section
Articles